Loading
A phase 2 trial of serplulimab in colorectal cancer, run by First Affiliated Hospital of Zhejiang University, now recruiting.
SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases is a phase 2, interventional study registered as NCT06850103 by First Affiliated Hospital of Zhejiang University, with a registry enrolment figure of 51 participants, started 2025-04-22 and due to reach its primary completion in 2027-12-31. Interventions recorded: short-course radiotherapy; CAPEOX/XELOX; Serplulimab; surgery. Conditions listed: Colorectal Carcinoma; Oligometastases; pMMR; MSS; iTNT. Primary outcome: 3-year PFS. Colorectal eligibility wording from the registry: "Histologically confirmed primary rectal adenocarcinoma, with MRI showing tumor location within 10cm from the anal verge". Sites: China. No results are recorded here; the registry entry is the source.
Shares Serplulimab, Mismatch-repair deficient (MSI-high) colorectal cancer, IMRT / IGRT (modern external beam), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Serplulimab, Mismatch-repair deficient (MSI-high) colorectal cancer, IMRT / IGRT (modern external beam), Colorectal cancer trials open today (registry snapshot) and the tag colorectal-deep-dive.
Shares Serplulimab, IMRT / IGRT (modern external beam), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Serplulimab, IMRT / IGRT (modern external beam), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Serplulimab, IMRT / IGRT (modern external beam), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Serplulimab, Colorectal cancer trials open today (registry snapshot), Rectal cancer, Immune checkpoint inhibitors and the tag colorectal-deep-dive.
Shares Mismatch-repair deficient (MSI-high) colorectal cancer, IMRT / IGRT (modern external beam), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Mismatch-repair deficient (MSI-high) colorectal cancer, IMRT / IGRT (modern external beam), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.